On May 20, 2025, Rani Therapeutics Holdings, Inc. entered a letter agreement to issue a new warrant for 13.16 million shares at $0.65 each and to lower existing warrants' exercise prices from $3.08 and $3.00 to $0.65, aiming to raise approximately $4.3 million.